Dividend Yield
Search documents
Verizon Dividend Yield Pushes Past 7%
Forbes· 2025-10-13 19:50
Group 1 - Verizon Communications shares are yielding above 7% based on its quarterly dividend of $2.76, with stock prices as low as $39.41 [1] - Historically, dividends have contributed significantly to the total return of the stock market, exemplified by the S&P 500 ETF performance from 1999 to 2012, where dividends provided a positive total return despite a decrease in share price [1] - Verizon has been growing its dividend for over 20 consecutive years, indicating a strong history of dividend growth [4] Group 2 - Dividend amounts are generally unpredictable and fluctuate with company profitability, making it essential to assess the sustainability of Verizon's current 7% yield [2] - The company is classified as an S&P 500 company, which enhances its status among large-cap companies [1]
RMT: 7% Yield, 11% Discount, Micro Caps Outperforming
Seeking Alpha· 2025-10-12 13:15
Core Insights - The article emphasizes the search for solid income opportunities in global markets, specifically targeting dividend yields between 5% to 10% or more, supported by strong earnings [1]. Group 1 - The investment group "Hidden Dividend Stocks Plus" manages a portfolio of up to 40 holdings at a time, providing resources such as a dividend calendar, weekly research articles, and trade alerts [1]. - Robert Hauver, the leader of the investing group, has over 30 years of investment experience and previously served as VP of Finance for an industry-leading corporation for 18 years, focusing on undercovered and undervalued income vehicles [2].
Sarasin Loads Up on Kimberly-Clark (KMB) With 964,000 Shares in Q3 2025
The Motley Fool· 2025-10-12 01:06
Core Viewpoint - Sarasin & Partners LLP has significantly increased its stake in Kimberly-Clark by acquiring 963,978 shares valued at approximately $119.87 million, raising its total holdings to 2,048,544 shares worth $251.27 million as of September 30, 2025 [1][2]. Company Overview - Kimberly-Clark reported a total revenue of $18.88 billion and a net income of $2.43 billion for the trailing twelve months (TTM) [4]. - The company offers a dividend yield of 4.22% as of October 9, 2025, with its stock priced at $119.55 [4]. Business Model - Kimberly-Clark manufactures and markets personal care products, consumer tissue, and professional hygiene solutions under well-known brands such as Huggies, Kleenex, Scott, and Kotex [5]. - The company generates revenue primarily through the sale of branded disposable consumer products, utilizing a global distribution network that includes supermarkets, mass merchandisers, and e-commerce channels [5]. Market Position - Kimberly-Clark is recognized as a leading global provider of personal care and tissue products, serving a diverse customer base that includes individual consumers, retail outlets, and commercial institutions across various sectors [6]. - The company has maintained a diversified portfolio of established brands, which supports its market presence [6]. Investment Insights - Despite a decline in stock price, down 15.9% over the year ending October 9, 2025, Kimberly-Clark's dividend history is notable, having increased dividends for over 50 years, making it a reliable choice for income-focused investors [3][9]. - The KMB position now constitutes 2.47% of Sarasin & Partners LLP's 13F reportable assets under management (AUM) as of September 30, 2025 [3].
Financial Services Company Wealth Oklahoma Began Investing in Allison Transmission. Is the Stock a Buy?
The Motley Fool· 2025-10-11 23:09
Core Viewpoint - Wealth Oklahoma has initiated a new position in Allison Transmission Holdings by acquiring 75,606 shares valued at approximately $6.4 million, representing 1.9% of its reportable U.S. equity assets as of Q3 2025 [1][2][3]. Company Overview - Allison Transmission designs and manufactures fully automatic transmissions and related parts for commercial, defense, and specialty vehicles, generating revenue primarily through product sales to original equipment manufacturers (OEMs) and aftermarket services [5][8]. - The company reported trailing twelve-month (TTM) revenue of $3.2 billion and net income of $762 million for the period ended June 30, 2025 [3][4]. Financial Performance - As of October 10, 2025, Allison Transmission's dividend yield was 1.3%, and shares were priced at $81.02, which is 35% below their 52-week high as of October 9, 2025 [3][4]. - The company's revenue for the first half of 2025 was $1.58 billion, a slight decrease from $1.61 billion in 2024 [9]. - Allison Transmission has revised its 2025 revenue expectations to between $3.1 billion and $3.2 billion, down from a previous estimate of $3.2 billion to $3.3 billion due to softness in demand in certain end markets [10]. Market Position - Allison Transmission is the world's largest manufacturer of medium and heavy-duty fully automatic transmissions, leveraging a broad distribution network and long-standing OEM relationships [9][11]. - The company serves a global customer base, focusing on commercial vehicle and defense markets [6][8]. Investment Rationale - Wealth Oklahoma's acquisition of Allison Transmission shares is seen as a strategic move, reflecting confidence in the company's potential recovery, especially following its recent acquisition of Dana Incorporated, which enhances its drivetrain and propulsion systems capabilities [11]. - With a price-to-earnings ratio of 9, Allison Transmission's valuation appears attractive, indicating a potential buying opportunity [12].
Sabra Health Care: SHOP Model As A Value Catalyst
Seeking Alpha· 2025-10-11 07:43
I am a financial analyst currently studying for the Chartered Financial Analyst (CFA) - I have learned to invest mostly by Mark Meldrum courses. My analyses follow an approach based on the triangulation between valuation by multiples, discounted cash flow (DCF) and Dividend Yield. In addition to individual research on the respective companies, drivers and risks. I focus on the Consumer Discretionary and Consumer Staples sectors, prioritizing companies with smaller capitalization and low institutional covera ...
How To Earn $500 A Month From JPMorgan Stock Ahead Of Q3 Earnings
Benzinga· 2025-10-10 11:54
JPMorgan Chase & Co. (NYSE:JPM) will release earnings results for the third quarter before the opening bell on Tuesday, Oct. 14.Analysts expect the New York-based company to report quarterly earnings at $4.86 per share, up from $4.37 per share in the year-ago period. JPMorgan is projected to report quarterly revenue of $45.42 billion, compared to $42.65 billion a year earlier, according to data from Benzinga Pro.On Oct. 7, UBS analyst Erika Najarian maintained JPMorgan with a Buy and raised the price target ...
Oil & Refining Gains May Fuel ExxonMobil's Q3: Time to Buy the Stock?
ZACKS· 2025-10-09 15:31
Core Insights - Exxon Mobil Corporation (XOM) anticipates a sequential increase in third-quarter 2025 earnings by up to $300 million, primarily driven by changes in oil prices and favorable refining margins [1][8] - The company expects its energy products business unit to generate earnings between $300 million and $700 million in the same quarter due to favorable industry refining trends [4][8] Oil & Natural Gas Price Impact - XOM projects a sequential earnings increase of $200 million in Q3 2025 due to natural gas price changes, with potential impacts ranging from a $200 million loss to a $200 million profit [2] - Average WTI spot prices for July, August, and September 2025 were $68.39, $64.86, and $63.96 per barrel, respectively, indicating a healthier pricing environment compared to the previous quarter [3] Production Outlook - ExxonMobil aims to increase its Permian production to 2.3 million barrels of oil equivalent per day by the end of the decade, up from approximately 1.6 million [5] - The company has made significant oil and gas discoveries in offshore Guyana, estimating recoverable reserves at 11 billion barrels of oil equivalent [6] Dividend and Stock Performance - XOM's current dividend yield is 3.47%, lower than the industry average of 4.4%, with competitors like BP and Chevron offering higher yields [7] - Over the past year, XOM's stock has declined by 4%, underperforming the industry's composite gain of 1% [8][12] Valuation Concerns - XOM is considered overvalued, trading at a trailing 12-month EV/EBITDA of 7.32X, which is higher than the industry average of 4.49X [14] - Compared to BP and Chevron, ExxonMobil's stock is currently priced at a premium [14] Future Outlook - The third-quarter 2025 results are expected to reflect a weaker oil pricing environment compared to the same period last year, with projected WTI prices declining in the coming years [10][11] - Despite a strong production outlook, the anticipated weakening of crude prices may negatively impact XOM's earnings [11]
Should You Buy Agnico Eagle Stock After a 52% Rally in 6 Months?
ZACKS· 2025-10-09 14:10
Key Takeaways Agnico Eagle shares soared 52% in six months, lifted by record gold prices and robust earnings.AEM advances key projects like Odyssey, Hope Bay and Detour Lake to boost future output.Strong liquidity, debt reduction and rising earnings estimates underscore AEM's growth outlook.Agnico Eagle Mines Limited's (AEM) shares have surged 52% in the past six months. The upside has been fueled by an upswing in gold prices to historic highs and AEM’s forecast-topping earnings performance, driven by highe ...
How To Earn $500 A Month From Levi Strauss Stock Ahead Of Q3 Earnings
Benzinga· 2025-10-09 12:14
Core Insights - Levi Strauss & Co. is set to release its third-quarter earnings results on October 9, with analysts predicting earnings of 31 cents per share, a decrease from 33 cents per share in the same period last year [1] - The company anticipates quarterly revenue of $1.50 billion, slightly down from $1.52 billion a year earlier [1] Dividend Information - Levi Strauss has appointed Chris Callieri as the new senior vice president and chief supply chain officer [2] - The company currently offers an annual dividend yield of 2.27%, translating to a quarterly dividend of 14 cents per share, or 56 cents annually [2] - To generate $500 monthly or $6,000 annually from dividends, an investment of approximately $264,207 or around 10,714 shares is required [2] - For a more modest income of $100 per month or $1,200 annually, an investment of $52,846 or around 2,143 shares is needed [2] Dividend Yield Calculation - The dividend yield is calculated by dividing the annual dividend payment by the stock's current price [3] - For instance, if a stock pays an annual dividend of $2 and is priced at $50, the yield is 4% [3] - Changes in stock price affect the yield; if the price increases, the yield decreases, and vice versa [3][4] Stock Performance - Shares of Levi Strauss rose by 0.8%, closing at $24.66 on Wednesday [4]
An easy way to value GMG and SHL shares
Rask Media· 2025-10-09 00:57
Group 1: Goodman Group (GMG) - Goodman Group's share price has decreased approximately 5.9% since the beginning of 2025, making it the largest ASX-listed property group in 2025 with operations across multiple continents including Australia, New Zealand, the UK, Japan, the US, and Brazil [1] - The company specializes in warehouses, large-scale logistics facilities, and business and office parks, aiming to build long-term relationships with customers and deliver high-quality assets [2] - The current dividend yield for Goodman Group shares is around 0.88%, which is lower than its 5-year average of 1.28%, indicating a potential decline in dividends or an increase in share price [6] Group 2: Sonic Healthcare (SHL) - Sonic Healthcare, listed in April 1987, is one of the largest pathology businesses globally, with operations in Australia, New Zealand, Europe, and North America, offering services such as laboratory medicine, pathology, diagnostic imaging, and corporate medical services [3][4] - The current price-sales ratio for Sonic Healthcare shares is 1.19x, which is below its 5-year long-term average of 1.94x, suggesting that SHL shares may be undervalued [7] - Sonic Healthcare focuses on acting in the best interests of doctors and patients, striving for medical excellence and being a desirable workplace [4]